Skip to main content

Table 2 Ethnic differences in the infectious burden and the prevalence of infections

From: Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease: a cross-sectional analysis

  Crude prevalence Age and sex adjusted OR (95%-CI)
  Dutch (n = 440) Moroccan (n = 272) Turkish (n = 320) Moroccan versus Dutch Turkish versus Dutch
IB
-High 38 (8.6) 103 (37.9) 138 (41.1)a 7.0 (4.6–10.8)b 10.8 (7.0–16.5)b
-Intermediate 110 (25.0) 155 (57.0) 165 (51.6)   
-Low 292 (66.4) 14 (5.1) 17 (5.3)   
HSV1 positive 281 (63.9) 269 (98.9) 308 (96.3)a 60.5 (18.9–193.3) 19.0 (10.2–35.5)
HSV2 positive 100 (22.7) 43 (15.8) 35 (10.9)a 0.68 (0.45–1.0) 0.45 (0.30–0.69)
HAV positive 217 (49.3) 261 (96.0) 310 (96.9)a 35.6 (18.4–69.2) 22.2 (27.6–110.5)
HBV positive 25 (5.7) 77 (28.3) 120 (37.5)a 6.8 (4.1–11.2) 13.6 (8.3–22.2)
HCV positive 1 (0.2) 1 (0.4) 0 (0)
H.pylori positive 252 (57.3) 267 (98.2) 313 (97.8)a 46.5 (18.6–116.0) 44.6 (20.2–98.2)
  1. Data are given as n (%) or as median (minimum-maximum), IB infectious burden measured by the number of infections (HSV1, HSV2, HAV, HBV, HCV and H.pylori) a participant was seropositive for. With the term infection we in this study refer to antibody seropositivity, a measure reflecting current or past infection. The subcategories are: low (0–2 infections), intermediate (3 infections) and high (4–6 infections); HSV1 herpes simplex virus 1, HSV2 herpes simplex virus 2, HAV hepatitis virus A, HBV hepatitis virus B, HCV hepatitis virus C, H.pylori Helicobacter pylori, OR odds ratio, CI confidence interval, a p-value univariate comparison < 0.001, b Comparison made between high IB and other